Comparison between Medico Remedies IPO and Sintercom India IPO.
Medico Remedies IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Sintercom India IPO is a SME Bookbuilding proposed to list at NSE SME.
| Medico Remedies IPO | Sintercom India IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Bookbuilding |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Aryaman Financial Services Ltd. | Pantomath Capital Advisors Pvt.Ltd. |
| Registrar | Cameo Corporate Services Ltd. | MUFG Intime India Pvt.Ltd. |
| Market Maker | Aryaman Capital Markets Ltd. | Innovate Securities Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Medico Remedies IPO is up to ₹10.42 Cr whereas the issue size of the Sintercom India IPO is up to ₹40.38 Cr. The final issue price of Medico Remedies IPO is ₹100.00 per share and of Sintercom India IPO is ₹65.00 per share.
| Medico Remedies IPO | Sintercom India IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹63.00 per share | |
| Issue Price (Upper) | ₹65.00 per share | |
| Issue Price (Final) | ₹100.00 per share | ₹65.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹0.00 per share | |
| Market Lot Size | 1200 shares | 2000 shares |
| Fresh Issue Size | 8,91,600 shares | 26,82,000 shares |
| Fresh Issue Size (Amount) | up to ₹8.92 Cr | up to ₹17.43 Cr |
| OFS Issue Size | 1,50,000 shares | 35,30,000 shares |
| OFS Issue Size (Amount) | up to ₹1.50 Cr | up to ₹22.95 Cr |
| Issue Size Total | 10,41,600 shares | 62,12,000 shares |
| Issue Size Total (Amount) | up to ₹10.42 Cr | up to ₹40.38 Cr |
Medico Remedies IPO opens on Jan 29, 2018, while Sintercom India IPO opens on Feb 05, 2018. The closing date of Medico Remedies IPO and Sintercom India IPO is Jan 31, 2018, and Feb 07, 2018, respectively.
| Medico Remedies IPO | Sintercom India IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Jan 29, 2018 | Feb 05, 2018 |
| Issue Close | Jan 31, 2018 | Feb 07, 2018 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Feb 08, 2018 | Feb 15, 2018 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Medico Remedies IPO P/E ratio is , as compared to Sintercom India IPO P/E ratio of .
| Medico Remedies IPO | Sintercom India IPO | |
|---|---|---|
| Financials | ||
| Promoter Shareholding (Pre-Issue) | ||
| Promoter Shareholding (Post-Issue) | ||
| P/E Ratio | ||
| Market Cap | ||
| ROE | ||
| ROCE | ||
| Debt/Equity | ||
| EPS | ||
| RoNW |
In the Medico Remedies IPO Retail Individual Investors (RII) are offered 5,20,800 shares while in Sintercom India IPO retail investors are offered 5,20,800 shares. Qualified Institutional Buyers (QIB) are offered in Medico Remedies IPO and 12,30,000 shares in Sintercom India IPO.
| Medico Remedies IPO | Sintercom India IPO | |
|---|---|---|
| Anchor Investor Reserveration | 18,40,000 shares | |
| Market Maker Reserveration | 57,600 shares | 3,34,000 shares |
| QIB | 12,30,000 shares | |
| NII | 5,20,800 shares | 9,28,000 shares |
| RII | 5,20,800 shares | 21,64,000 shares |
| Employee | 50,000 shares | |
| Others | ||
| Total | 10,41,600 shares | 62,12,000 shares |
Medico Remedies IPO subscribed 1.84x in total, whereas Sintercom India IPO subscribed 38.92x.
| Medico Remedies IPO | Sintercom India IPO | |
|---|---|---|
| QIB (times) | 5.80x | |
| NII (times) | 1.16x | 203.72x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 2.52x | 16.41x |
| Employee (times) | 3.92x | |
| Other (times) | ||
| Total (times) | 1.84x | 38.92x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
